Greatview Aseptic Packaging (468) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
26 Aug, 2026Executive summary
Revenue for the six months ended 30 June 2025 was RMB1,006.7 million, down 1.6% year-over-year, with net profit dropping 32.4% to RMB83.0 million due to lower gross margin and absence of discontinued operations profit.
International segment revenue grew 11.8% to RMB253.0 million, while PRC segment revenue declined 5.5% to RMB753.7 million; dairy segment revenue fell 4.4% and NCSD segment rose 5.2%.
Gross margin decreased to 16.1% from 18.0% year-over-year, and net profit margin fell to 8.2% from 12.0%.
The company advanced digital transformation, enhanced supply chain integration, and focused on green, sustainable packaging solutions.
Trading in shares remains suspended since 19 February 2025 due to insufficient public float after a major share acquisition.
Financial highlights
Revenue: RMB1,006.7 million (down 1.6% year-over-year).
Gross profit: RMB162.1 million (down 11.8% year-over-year).
Net profit: RMB83.0 million (down 32.4% year-over-year).
Earnings per share: RMB0.06 (down 33.3% year-over-year).
Cash and cash equivalents: RMB568.6 million as of 30 June 2025.
No interim dividend declared.
Outlook and guidance
Plans to deepen cooperation with existing customers, expand market share in PRC, and pursue international growth through localized operations and new product development.
Focus on technological innovation, sustainability, and operational excellence, leveraging digital intelligence and AI.
Continued emphasis on product innovation, cost control, and supply chain resilience.
Latest events from Greatview Aseptic Packaging
- Net profit plunged 91.7% on lower sales and margins, with trading suspension and legal risks ongoing.468
H1 2026 - Sharp profit decline, restructuring, and internal control issues drive major remedial actions.468
H2 2025 - Revenue and profit plunged amid governance overhaul, investigations, and trading suspension.468
H2 2024 - Net profit rose 17.7% despite a 13.9% revenue drop, amid restructuring and takeover activity.468
H1 2024